Amorfix Life Sciences Ltd

(ARFXF)

By |

Profile

ProMIS Neurosciences Inc is a biotech company.

Contact Information

Website: www.promisneurosciences.com
Email: info@promisneurosciences.com
Main Phone: +1 415 341-5783
Address: 1920 Yonge Street
Address 2: Suite 200
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M4S 3E2

Issuer Information

Exchange: OTCQB
CEO: Elliot Goldstein
Employees: 9
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.14 $ -0.00382 (-2.58%)
Last Price 0.14 Change $ -0.00382 Change % -2.58 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.14 High 0.15 Low 0.14 Prev Close 0.15
Last Trade Volume 96,847 52 Wk Hi 0.70 52 Wk Low 0.14
Market Cap 35.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 246,829,069.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCQB
Form Type Form Description Pages Date
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2018-05-03
D/A Amendment to a previously filed Form D 1 2017-09-11
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2017-08-18
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2017-03-27
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2017-03-08
D/A Amendment to a previously filed Form D 1 2016-11-22
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2016-09-22
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2016-08-24
D/A Amendment to a previously filed Form D 1 2016-06-15
D Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act 1 2016-04-14